| Identification | Back Directory | [Name]
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetate | [CAS]
1034975-62-6 | [Synonyms]
4-(4-methylpiperazine-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl) amino] teflon acetate
4-(4-METHYLPIPERAZIN-1-YL)-2-[(TETRAHYDROPYRAN-4-YL)(2,2,2-TRIFLUOROACETYL)AMINO]BENZOIC ACID TRIFLU
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid fluoroacetate
4-(4-Methyl-1-piperazinyl)-2-[(4-tetrahydropyranyl)(2,2,2-trifluoroacetyl)amino]benzoic Acid Trifluoroacetate
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetate
4-(4-carboxy-3-(2,2,2-trifluoro-N-(tetrahydropyran-4-yl)acetamido)phenyl)-1-methylpiperazin-1-ium 2,2,2-trifluoroacetate
4 - (4 - methyl - 1 - piperazine) - 2 - [(4 - pyran 4 hydrogen) (2,2,2 - trifluoro acetyl) amino] benzoic acid trifluoroacetic acid salt | [EINECS(EC#)]
-0 | [Molecular Formula]
C21H25F6N3O6 | [MDL Number]
MFCD28137881 | [MOL File]
1034975-62-6.mol | [Molecular Weight]
529.43 |
| Hazard Information | Back Directory | [Uses]
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetateis an intermediate of Entrectinib which is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that has spread to other parts of the body. |
|
|